Received May 26, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | UNK | — |
not sure if she ever went back to receive the second dose; This non-serious case was reported by a consumer via call center representative and described the occurrence of incomplete course of vaccination in a female patient who received Herpes zoster (Shingrix) for prophylaxis. Previously administered products included Shingrix (patient received first dose 2 to 3 years ago). On an unknown date, the patient did not receive the 2nd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced incomplete course of vaccination (Verbatim: not sure if she ever went back to receive the second dose). The outcome of the incomplete course of vaccination was not applicable. Additional Information: GSK Receipt Date: 20-MAY-2025 This report was submitted via the online direct entry reporting system. The patient did not have any lot number information to provide. The reporter was a patient that received her first dose of Shingrix 2 to 3 years ago from her pharmacist at her local pharmacy, and was not sure if she ever went back to receive the second dose. The patient reported that she normally received vaccines in her left arm, but this was not confirmed. The patient thought the Shingrix first dose was administered as an IM injection, but this was not confirmed. Till the time of reporting the patients did not receive the second dose of Shingrix, which led to incomplete course of vaccination.